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Abstract
Background: Resistin is a cysteine rich protein, mainly expressed and secreted by circulating human mononuclear cells.
While several factors responsible for transcription of mouse resistin gene have been identified, not much is known about
the factors responsible for the differential expression of human resistin.
Methodology/Principal Finding: We show that the minimal promoter of human resistin lies within ,80 bp sequence
upstream of the transcriptional start site (2240) whereas binding sites for cRel, CCAAT enhancer binding protein a (C/EBP-
a), activating transcription factor 2 (ATF-2) and activator protein 1 (AP-1) transcription factors, important for induced
expression, are present within sequences up to 2619. Specificity Protein 1(Sp1) binding site (2276 to 2295) is also present
and an interaction of Sp1 with peroxisome proliferator activating receptor gamma (PPARc) is necessary for constitutive
expression in U937 cells. Indeed co-immunoprecipitation assay demonstrated a direct physical interaction of Sp1 with
PPARc in whole cell extracts of U937 cells. Phorbol myristate acetate (PMA) upregulated the expression of resistin mRNA in
U937 cells by increasing the recruitment of Sp1, ATF-2 and PPARc on the resistin gene promoter. Furthermore, PMA
stimulation of U937 cells resulted in the disruption of Sp1 and PPARc interaction. Chromatin immunoprecipitation (ChIP)
assay confirmed the recruitment of transcription factors phospho ATF-2, Sp1, Sp3, PPARc, chromatin modifier histone
deacetylase 1 (HDAC1) and the acetylated form of histone H3 but not cRel, C/EBP-a and phospho c-Jun during resistin gene
transcription.
Conclusion: Our findings suggest a complex interplay of Sp1 and PPARc along with other transcription factors that drives
the expression of resistin in human monocytic U937 cells.
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Introduction
Resistin/FIZZ3 (Found in Inflammatory Zone) is a novel
cysteine rich hormone expressed in the white adipose tissue in
mice and in mononuclear cells in humans [1]. In genetic and diet
induced mouse models of obesity resistin levels were elevated and
therefore was concluded to be a link between obesity and insulin
resistance [2]. Resistin is expressed at very low levels in human
adipocytes and does not seem to correlate with insulin resistance
[3–9]. Interestingly, human resistin protein is detected at a high
level in mononuclear cells [4,10] and has been shown to be
upregulated in inflammation. Also, a direct correlation between
inflammatory markers and resistin is evident in humans [11–15].
Striking similarities exist between adipocytes and macrophages
and these include the secretion of many pro-inflammatory
cytokines and chemokines such as Tumor Necrosis Factor-a
(TNF-a), interleukins, Monocyte chemotactic protein-1, Matrix
metalloproteases, by the adipocytes [16,17]. Also, adipocytes are
sensitive to stimulation with LPS (Lipopolysaccharide) and TNF-a,
a characteristic feature of macrophages. Conversely, many of the
proteins secreted by adipocytes such as leptin, adiponectin and
resistin are also involved in inflammatory responses [18,19].
Transcription factor PPARc, which is specific to adipocytes, has
been shown to be important in macrophages as well [20]. Thus, it
is evident that a considerable overlap exists, possibly due to the
common mesodermal origin, between the adipose tissue and
macrophages.
Substantial evidences exist supporting the functional differences
between human and mouse resistin proteins. It is also likely that,
different regulatory mechanisms for the human and mouse resistin
gene transcription may be expected. There are a few reports to
demonstrate the role of C/EBP-a in the regulation of both human
and mouse resistin genes [21–23]. A 224 bp segment of the mouse
resistin gene promoter carries the C/EBP-a binding site, which is
necessary and sufficient for transcription from the resistin gene
promoter. Furthermore, C/EBP-a binding was associated with the
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Human resistin gene (hres) promoter was also activated by C/EBP-
a expression in mouse 3T3L1 cells [23]. It was further shown that
thiazolidinediones (TZD) and non-TZD PPARc ligands down-
regulate resistin gene expression. Further, Retinoid X receptor
(RXR) agonists, which activate the PPAR/RXR heterodimer,
downregulate resistin gene expression in 3T3L1 adipocytes
[21,24–25]. We earlier showed that the PPARc response element
(PPRE) present in the intron X of mouse resistin gene governs the
TZD responsiveness of resistin gene expression [26]. Downregu-
lation of resistin in 3T3L1 cells has also been reported to be
signaled via the PI3 and MAP kinase pathways [24]. Furthermore,
one of the adipogenic transcription factor, adipocyte determina-
tion and differentiation dependent factor 1/sterol regulatory
element-binding protein 1c (ADD1/SREBP1c) was shown to bind
to the hres gene promoter and ectopic expression of ADD1/
SREBP1c significantly increased the expression of resistin mRNA
in mouse adipocytes [23]. However, another report demonstrated
that SREBP1c and cyclic AMP response-element- binding protein
(CREB) had no effect on resistin gene expression in 3T3L1
preadipocytes [25]. These discrepancies in the function of various
transcription factors in resistin gene regulation might be due to the
variation in the system used by the different investigators. Hence it
becomes pertinent to understand the possible role of different
transcription factors mediating the regulation of the expression of
resistin where it is highly expressed, namely the monocytes/
macrophages.
Despite the well documented involvement of PPARc in
regulating hres expression in human macrophages, paradoxically
PPARc binding site has not been found within the hres regulatory
sequences. We highlight the role of transcription factors
responsible for hres expression in the human monocytic cell line,
U937. Our findings suggest that Sp1 is a crucial transcription
factor that drives the expression of human resistin in U937 cells.
We also find that PMA and LPS increase the level of hres mRNA
while pyrrolidine dithiocarbamate (PDTC), which is an inhibitor
of Sp1 binding, abrogates the basal, and also PMA/LPS induced
resistin mRNA levels. Furthermore, PPARc plays an important
role in the regulation of hres gene expression by interacting directly
with Sp1 transcription factor.
Materials and Methods
Cloning of the promoter sequences
The amplicon corresponding to +32 to 2673 region of hres
gene was cloned into pGL3Basic vector using KpnIa n dHindIII
restriction sites (pGL3hres0.7K). pGL3hres0.65K corresponding
to the region 2630 to +32 region was generated by digesting
pGL3hres0.7K with KpnIa n dSmaI followed by end filling and
self-ligation. The amplicon corresponding to 2238 to +32
was cloned into KpnIa n dHindIII sites of pGL3Basic
(pGL3hres0.25K). The PCR amplified fragment from 2673 to
2284 was cloned in KpnIa n dNcoI enzyme sites in pGL3Basic
(pGL3hres0.4K). The 21262 to 2284 region and 22140 to
2284 promoter regions were amplified and primarily cloned in
pCR2.1 vector (Invitrogen) followed by sub cloning in
pGL3Basic into HindIII XhoIa n dXhoI KpnI sites to generate
pGL3hres1K and clones, respectively. The pGL3hres0.7K
construct was digested with KpnIa n dApaIa n dt h ep l a s m i dr e -
ligated to generate pGL3hres0.34K construct. pGL3hres0.39K
construct was generated by PCR-amplification of 2367 to +32
region of resistin gene using pGL3hres0.7K plasmid as the
template and the amplicon inserted into KpnIa n dHindIII sites
of pGL3Basic vector.
Prediction of transcription factor binding sites regulating
human resistin gene expression
Transcription factor binding sites in human resistin gene
promoter were predicted using Matinspector algorithm (http://www.
genomatix.de and http://www.cbrc.jp/research/db/TFSEARCH.
html).
Site-directed mutagenesis of promoter constructs
Promoter constructs with site-directed mutations of the various
transcription factor binding sites in hres gene promoter were
generated using pGL3hres0.7K plasmid as the basic plasmid. A
detailed description of the methodology is given in the Text S1.
Transient transfection of promoter clones
Transfection of U937 cells was performed using Electroporator
(Bio-Rad) using exponential decay method. 25610
6 cells were
electroporated with 40 mg reporter plasmid and 10 mg pSVbGAL
(Promega) plasmid at 300 V and 950 mF. Cells were harvested 24
or 48 hours post transfection and assayed for luciferase and b-Gal
reporter enzymes using the luciferase and b-Gal assay systems
from Promega as per the manufacturer’s instructions. Experiments
were repeated at least 3 times.
Stimulation of U937 cells
U937 cells (6610
6) were treated with 10 nM, 20 nM and
50 nM PMA. The cells were also stimulated with either 100 nM
PMA, 1 mM PDTC, 5 mg/ml LPS alone or PDTC in combina-
tion with PMA and LPS for 3 hours. RNA was isolated and
quantitative RT-PCR was performed to monitor resistin mRNA
level.
Electrophoretic mobility shift assay (EMSA)
Preparation of Nuclear Extracts. Nuclear extracts were
prepared according to the method described by Dignam et al [27].
Briefly, cells were washed three times with ice- cold PBS
containing 1 mM PMSF. Lysis buffer (30 mM Tris pH 7.5,
1 mM Mg-acetate, 1% NP- 40, 1 mM PMSF) was added at five
times the packed cell volume (PCV) and vortexed. Nuclei were
harvested by centrifugation at 1600 rpm at 4uC. The supernatant
was discarded and four PCVs of nuclear extraction buffer (10 mM
HEPES-KOH pH 7.5, 420 mM NaCl, 1.5 mM MgCl2, 10%
glycerol, 1 mM PMSF, 1 mM DTT, 3 mg/ml Leupeptin, 1 mg/ml
Aprotinin) was added. The tubes were incubated on ice for 60
minutes with gentle shaking. The debris was removed by
centrifugation at 13000 rpm for 10 minutes at 4uC and the
supernatant containing the nuclear extract was stored in small
aliquots at 270uC. Protein concentration was estimated as
described [28].
Preparation of Radio labeled Probe. 100 ng of the
respective oligonucleotides were end labeled using 5 units of
polynucleotide kinase (NEB) in 1X buffer with P
32 c-ATP for one
hour at 37uC. The reaction was stopped by the addition of EDTA
and the labeled probe was purified using a G-50 column.
Electrophoretic mobility shift assay. EMSAs were
performed using nuclear extract from U937 cells. The reaction
mix contained 7.5 mg of nuclear protein, 1 ng of labeled
oligonucleotide, 1 mg poly dIdC and 1X EMSA binding buffer.
The compositions of the binding buffers for the transcription
factors AP-1: 50 mM Tris-Cl, pH 8.0, 12.5 mM MgCl2,1m M
EDTA, 1 mM DTT, 10% glycerol; c-Rel: 10 mM Tris-Cl,
pH 7.5, 100 mM NaCl, 1 mM EDTA, 5 mM DTT, 100 mg/ml
BSA, 4% glycerol, and Sp1: 10 mM Tris-Cl, pH 7.5, 75 mM
KCl, 0.1 mM EDTA, 2.5 mM MgCl2, 0.25 mM DTT, 10%
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competitors, both specific (self or consensus) as well as non-specific
oligonucleotides.
For super-shift of protein-DNA complexes, 2 mg of respective
antibodies were used in binding reaction. The reaction mixture
was incubated on ice for 20 minutes with the cold competitor,
followed by incubation with labeled oligonucleotide for another 30
minutes. After electrophoresis on 7% TGE-polyacrylamide gel,
the gel was dried and autoradiographed in a phosphorimager.
Chromatin Immuno- Precipitation assay (ChIP)
U937 cells were seeded at a concentration of 1610
6/ml in a
100 mm tissue culture dish in RPMI 1640 supplemented with
10% FBS. Approximately 25610
6 cells were stimulated with
5 ng/ml PMA for 5 hours. Cross-linking was performed by adding
formaldehyde to a final concentration of 1% at room temperature
for 10 minutes and reaction stopped by the addition of 125 mM
glycine. Cells were washed with ice-cold phosphate buffered saline
containing 0.1 mM PMSF. Cell pellets, collected by centrifugation
at 2000 rpm at 4uC, were resuspended in 1 ml of ChIP sonication
buffer (1% Triton X-100, 0.1% Deoxycholate, 50 mM Tris-HCl,
pH 8.1, 150 mM NaCl, 5 mM EDTA, 0.1 mM PMSF, 2 mg/ml
aprotinin and leupeptin) and placed on ice for 10 minutes. DNA
was sheared by sonication and the cell debris was pelleted by
centrifugation at 14,000xg for 15 minutes. The supernatant was
collected in fresh tubes and pre cleared with Protein G sepharose
equilibrated with salmon sperm DNA for 30 minutes at 4uC. The
pre-cleared whole cell extract was incubated with or without the
antibodies, as described in the legend, at 4uC overnight. 10% of
the volume was frozen and kept aside as input before the addition
of the antibodies.
The immune complex was precipitated by incubation of the
samples with Protein G sepharose equilibrated with salmon sperm
DNA at 4uC for 2 hours. The samples were centrifuged at
2500 rpm at 4uC for 1 minute and the supernatant was discarded.
The Protein G sepharose beads were washed with cold ChIP
sonication buffer containing no protease inhibitors. This was
followed by sequential washes with low salt wash buffer (1% Triton
X-100, 0.1% sodium deoxycholate, 50 mM Tris pH 8.0, 150 mM
NaCl and 5 mM EDTA), high salt wash buffer (1% Triton X-100,
0.1% sodium deoxycholate, 50 mM Tris pH 8.1, 500 mM NaCl
and 5 mM EDTA) and LiCl wash buffer (0.25 M LiCl, 0.5% NP-
40, 0.5% sodium deoxycholate, 1 mM EDTA and 10 mM Tris
pH 8.1). The immune complex was eluted with 1% SDS, 0.1 M
NaHCO3. The cross linking was reversed by incubation at 65uC
for 4 hours followed by ethanol precipitation of the proteins and
DNA. Proteinase K digestion was performed at 55uC for 1 hour.
The immunoprecipitated DNA was extracted by phenol:chloro-
form. PCR was performed using forward (59 TGTCATTCT-
CACCCAGACACA 39) and reverse (59 TGGGCTCAGCTAAC-
CAAATC 39) primers to generate a specific 535 bp fragment
corresponding to the hres gene promoter.
RT-PCR for human resistin
Human resistin was amplified by RT- PCR with total RNA
isolated from U937 cells using Trizol (Invitrogen). Upstream (59
CG AGA TCT ATG AAA GCT CTC TGT CTC CTC CTC G
39) and downstream (59 GGA ATT CCC TCA GGG CTG CAC
ACG ACA 39) primers were used for RT-PCR which was
performed in a GeneAmpR PCR system 9700 (Applied Biosys-
tems) using Access RT-PCR system (Promega Corporation) with
the following cycles: 48uC for 45 minutes; 94uC for 2 minutes;
followed by 30 cycles of 94uC, 58uC, 68uC for 30 seconds each
and finally 72uC for 7 minutes. RT-PCR of GAPDH was used as
an internal control. The amplified products were resolved on a
1.5% agarose gel and the intensity of bands analyzed using
Quantity One software (Bio-Rad).
Immuno-precipitation
U937 cells were washed in PBS and centrifuged at 800 to
1000 rpm for 5 minutes to harvest the cells. Ice-cold modified
RIPA buffer (50 mM Tris-HCl, pH 7.4, 1% NP-40, 0.25% Na-
deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 mg/
ml each of aprotinin, leupeptin, pepstatin, 1 mM Na3VO4,1m M
NaF) was added to cells and gently rocked on a rocker at 4uC for
15 minutes for cell lysis. The lysate was centrifuged at 14,000xg for
15 minutes at 4uC. The cell lysate was pre-cleared by adding
100 ml of 50% Protein G sepharose bead slurry per 1 ml of cell
lysate. The supernatant was incubated with specific antibody
overnight at 4uC with gentle rocking. The immune complex was
captured by the addition of 100 ml Protein G sepharose. The
sepharose beads were washed 3 times with 800 ml ice-cold RIPA
buffer and resuspended in 60 ml2 6 sample buffer, followed by
elution through boiling. The immune complexes were fractionated
on 12% SDS-PAGE followed by western blotting with appropriate
antibodies.
‘Immuno-pullout’ of specific transcription factors from
nuclear extracts
Nuclear extract from U937 cells was dialyzed against 16 Sp1
binding buffer at 4uC for one hour. Protein concentration of the
dialyzed nuclear extracts was determined by the Bradford method.
30 mg of the dialyzed nuclear extracts were incubated with 2 mg
each of anti-Sp1, anti- Sp3 and anti-PPARc antibodies along with
Protein G sepharose beads for 4 hours at 4uC with gentle shaking.
The supernatants were collected by centrifugation at 5000 rpm for
2 minutes at 4uC. 7.5 mg of the supernatant was used to perform
EMSA as described earlier.
Results
Delineation of the human resistin gene promoter
sequences
As a first step in understanding the regulation of hres gene
expression the DNA sequence elements required to drive the
expression of human resistin in U937 cells were delineated.
Different plasmid constructs carrying defined regions upstream of
the human resistin translation start site were generated in pGL3
Basic reporter plasmid (Promega) (Figure 1A). The various deletion
constructs of the putative promoter were transfected into U937 cells
along with pSVbGal vector in a ratio of 8:2. Cells were harvested at
24and48 hours post transfectionandluciferaseand b-galactosidase
assays were performed. Relative luciferase units (RLU) normalized
to b-Gal activity for 48 hours post transfection are presented in
Figure 1A. pGL3hres0.34K construct exhibited maximal expression,
indicating that the optimal promoter lies within 317 nucleotide
upstream of the initiating ATG. Negligible luciferase gene
expression was observed in cells transfected with pGL3hres0.25K
(Figure 1A) suggesting that the optimal promoter that drives the
expression of human resistin might be present within the 80
nucleotide stretch that is absent in pGL3hres0.25K construct.
pGL3hres0.7K, pGL3hres0.65K pGL3hres0.39K showed significant
luciferasereportergene expressionalbeitlesser than pGL3hres0.34K
(Figure 1A). Sequences further away from 2340 contain possible
negative regulatory elements so much so that the region extending
up to 22300 nucleotide upstream showed negligible expression of
luciferase reporter gene (data not shown). Constructs pGL3hres2K,
pGL3hres1K and pGL3hres0.4K, which are devoid of 284 bp
Regulation of Human Resistin
PLoS ONE | www.plosone.org 3 March 2010 | Volume 5 | Issue 3 | e9912Figure 1. Delineation of the optimal promoter of human resistin. A. The regulatory sequences of hres gene were cloned upstream of
luciferase (luc) reporter gene in pGL3Basic vector. These constructs were transfected into U937 cells along with pSVb-Gal plasmid and expression of
luciferase gene was assayed 48 hours post transfection. B. Putative transcription factor binding sites in human resistin gene. The sequence of the hres
gene promoter is shown and numbered relative to the first ATG. The exons 1 and 2 sequences are underlined. The transcription start site (TSS) is
indicated by a blue arrowhead and the translation start site by an arrow. AP-1, c-Rel, Sp1 and C/EBP-a binding sites are indicated.
doi:10.1371/journal.pone.0009912.g001
Regulation of Human Resistin
PLoS ONE | www.plosone.org 4 March 2010 | Volume 5 | Issue 3 | e9912upstream of ATG, were not able to drive the expression of luciferase
reporter gene. These results point towards the importance of the cis-
acting elements present in the region between translation start site
and-673indriving resistingene expression invivo. More particularly
the sequence between nucleotide 2316 to +32 appears to be critical
for resistin gene transcription.
Prediction of transcription factor binding sites in the 59
flanking regions of human resistin gene
In order to identify the trans-acting factors involved in regulating
resistin gene transcription, in silico analysis of the upstream 673 bp
sequence of hres gene using the Matinspector software (http://www.
genomatix.de and http://www.cbrc.jp/research/db/TFSEARCH.
html) was carried out. The presence of a number of transcription
factor binding sites (Figure 1B) which included c-Rel (2281 to
2294), C/EBP-a (2221 to 2233), CREBP-1/ATF -2 (2599 to
2619), AP-1 (2647 to 2657) and Sp1 (2276 to 2295) that might
be potential regulators of constitutive and induced expression of
resistin in human monocytic cells could be seen. Interestingly, the
absence of TATA box element within the human resistin gene
promoter points to the possibility of resistin gene transcription being
regulated by an ‘‘initiator promoter’’ [29–32].
Sp1 binds specifically to its cognate motif present within
the human resistin gene promoter
TATA-less promoters are regulated by the involvement of Sp-
like factors which act as tethering agents to recruit specific
transcription factors [29,31]. We, therefore, investigated the actual
interaction, if any between resistin gene promoter and Sp1 factor,
more so given the presence of Sp1 binding site predicted in-silico.
The interaction of the Sp1 binding site in human resistin gene with
Sp1 transcription factor present in U937 cells was assessed by
performing EMSA using radio labeled oligonucleotide corre-
sponding to hres Sp1 binding motif (2276 to 2295). The hres
specific Sp1 binding sequence showed strong binding to factors
present in U937 nuclear extract generating two prominent
protein-DNA complexes (Figure 2A, lane 2). The binding was
abolished with homologous competition using unlabeled hres Sp1
oligonucleotide (Figure 2A, lane 3) and also with consensus Sp1
oligonucleotide (Figure 2A, lane 5) demonstrating the specificity
and authenticity of binding. There was no effect on the complex
formation when binding was carried out in the presence of
unlabeled polyhedrin gene promoter (Figure 2A, lane 4) [32] used
as a non-specified control. To categorically demonstrate that the
factor binding to Sp1 motif, present within the resistin gene, is
indeed Sp1, super shift assays were carried out. It could be
observed that anti-Sp1 antibodies could super-shift the protein-
DNA complex (Figure 2A, lane 6) confirming the presence of Sp1
in the complex. Additionally, anti-Sp3 antibodies could also super-
shift the protein-DNA complex (Figure 2A, lane 7) thereby
demonstrating the presence of Sp3 factors in the protein-DNA
complex. On the other hand, anti-Sp4 antibodies did not have any
effect on the formation of the protein-DNA complex (Figure 2A,
lane 8). These results demonstrate that the putative hres Sp1
binding site specifically recruits Sp1 and Sp3 transcription factors
present within U937 nuclear extracts, either as a heterodimer of
Sp1 and Sp3 or as a homodimer of Sp3. Furthermore the complex
formation does not involve Sp4 factors.
Endogenous AP-1 binds to its cognate motif in the
human resistin gene promoter
The AP-1 transcription factor is known to be involved in
regulation of genes under various conditions of stress. That resistin
is pro- inflammatory molecule was earlier reported [15] thereby
suggesting that human resistin could be transcriptionally regulated
by factors like AP-1, the cognate motifs for which were indeed
present (Fig. 1B) within the resistin gene upstream regulatory
sequences (2657 to 2648). Experiments were, therefore, designed
to document the interaction between hres AP-1 motif and AP-1
factors present in U937 nuclear extracts using EMSA. Consensus
AP-1 oligonucleotide was radio labeled and incubated with the
nuclear extract prepared from U937 cells. As expected, the
consensus AP-1 oligonucleotide could bind to AP-1 proteins
present in the U937 nuclear extracts (Figure 2B, lane 5). There
was no effect on the complex formation when binding was carried
out in the presence of unlabeled competitor oligonucleotides
carrying hres gene promoter sequence spanning nucleotides 2221
to 2233 present upstream of ATG and devoid of AP-1 recognition
motif (Figure 2B, lane 3). Homologous competition using
consensus AP-1 resulted in the disappearance of the AP-1 complex
(Figure 2B, lane 4) pointing to the specificity of the DNA protein
interaction thereby clearly indicating that the complex is not an
artifact generated by non-specific protein binding. Authenticity of
these complexes were established by competition analyses using
100 and 2006(Figure 2B, lanes 2 and 1, respectively) molar excess
of oligonucleotides corresponding to the putative AP-1 binding site
spanning 2647 to 2657 of the hres gene promoter. These results
clearly demonstrate that AP-1 transcription factor recognizes the
cognate AP-1 binding sequence present within the hres gene
promoter.
Endogenous c-Rel binds to the cognate c-Rel binding
motifs in the human resistin gene promoter
The presence of c-Rel binding motif, overlapping with the Sp1
motif, within the upstream (2281 to 2294) hres gene regulatory
sequences tempted us to investigate direct binding of cRel factor to
the hres c-Rel cognate motif. c-Rel which is a member of the Rel/
NFkB family of transcription factors, forms homo- or heterodi-
meric complexes with other members of the family to regulate
normal hemopoietic and immune cell function. Radio labeled
oligonucleotide corresponding to the hres c-Rel binding motif
(2281 to 2294) was incubated with U937 nuclear extract as well
as with nuclear extract from 293T cells over-expressing c-Rel.
EMSA was performed to check the interaction of c-Rel with the
cognate binding motifs present within the hres upstream DNA
sequence elements. It could be observed that c-Rel sequence motif,
present within the hres promoter, forms a complex with U937
nuclear extract and also nuclear extract from 293T cells over-
expressing c-Rel (Figure 2C, lanes 3 and 5, respectively) but not
when nuclear extract was prepared from normal 293T cells (lane
2). However, when U937 nuclear extract (lane 3) was used, the
intensity of the complex is low as compared to the complex (lane 5)
formed with the over-expressed c-Rel present in 293T cells. This is
perhaps a reflection of the abundance of the c-Rel protein in the
over-expressing 293T cells. It could also be seen that the size of the
complex formed with U937 nuclear extract was lower as
compared to that formed with nuclear extract from 293T cells
over- expressing c-Rel probably pointing to the formation of P65
c-Rel homodimers in the case of 293T cells over-expressing c-Rel
as compared to the formation of P50/P65-c-Rel heterodimers in
U937 cells. This protein-DNA complex is abolished (Figure 2C,
lane 8) upon competition with unlabelled consensus c-Rel
oligonucleotide and also sequences corresponding to homologues
hres c-Rel motif (lanes 4, 6) but is unaffected in the presence of non-
specific cold competition (lane 7). These results indicate that the c-
Rel protein binds to putative binding site, present within 2281 to
Regulation of Human Resistin
PLoS ONE | www.plosone.org 5 March 2010 | Volume 5 | Issue 3 | e9912Figure 2. Sp1, AP-1 and c-Rel bind to their cognate motifs present within the hres regulatory sequences. A. Sp1 binds specifically to the
hres cognate motif. EMSA with Sp1 binding motif using U937 cells and supershift with Sp1, Sp3 and Sp4 antibodies. EMSA using nuclear extract
prepared from U937 cells shows AP-1 binding to its hres cognate motif (B) and weak binding of c-Rel to its hres cognate motif (C). Arrows indicate the
position of binding of the corresponding trans-acting factors to their cognate motif and the super-shifts using antibodies. These experiments were
repeated two times.
doi:10.1371/journal.pone.0009912.g002
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Rel in resistin gene regulation in vivo.
Sp1 transcription factor regulates the constitutive
expression of human resistin in U937 cells
Having shown the presence of Sp1 cognate motifs and the in-
vitro binding of Sp1 factor present in the nuclear extracts of U937
cells, we attempted to examine the functional significance of this
interaction. Site-directed mutagenesis of the individual transcrip-
tion factor binding sites was performed and the mutated sequences
were cloned upstream of luciferase reporter gene in pGL3 Basic
plasmid. A schematic representation of the various mutated
constructs is given in Figure 3 (left half). The various mutant
constructs were transfected into U937 cells and the expression of
luciferase reporter gene was assayed. It could be seen that
mutation in AP-1 site did not change the transcriptional activation
of luciferase whereas mutations in c-Rel binding site resulted in
only a slight decrease in promoter activity compared to full length
construct, pGL3hres0.7K (Figure 3, right half). A similar decrease
in luciferase activity was observed when both AP-1 and c-Rel
binding sites were mutated. Interestingly, mutations in the Sp1
binding site of human resistin showed a significant decrease in the
expression of luciferase reporter gene. Similarly, mutation of both
AP-1 and Sp1 binding sites resulted in a decrease in promoter
activity that is comparable to the Sp1 Mut construct (Figure 3).
The significant loss of promoter activity in Sp1 mutant construct
suggests that binding of Sp1 transcription factor to its cognate
motif in TATA-less hres gene promoter is an important step in the
Figure 3. Sp1 binding is important for human resistin gene promoter activity. A schematic representation of the human resistin gene
promoter constructs with mutations in the various transcription factor binding motifs is shown. The location of transcription factor binding sites is
indicated by different symbols given in the inset. Mutated bases are indicated as blue. The various mutant promoter constructs were transfected into
U937 cells and the expression of luciferase reporter gene was assessed relative to the wild-type pGL3hres0.7K construct. Experiments were repeated
three times in duplicate.
doi:10.1371/journal.pone.0009912.g003
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basal level of resistin gene expression in U937 cells.
In order to address the question whether Sp1 actually induces
the transcription of endogenous resistin gene, two sets of
experiments were carried out. In the first experiment U937 cells
were transfected with plasmid over-expressing Sp1, Sp3 or PPARc
[33] and the expression of human resistin gene was measured
under such conditions. It could be clearly seen that upon over-
expression with Sp1 or Sp3 (Figure S2, bar 2 and 3), resistin gene
transcription was significantly enhanced which was expectedly
reduced upon over-expression with PPARc (Figure S2 bar 4). In
parallel experiment, HEK cells were co-transfected with plasmid
constructs carrying resistin gene promoter, with or without Sp1
cognate motif, along with Sp1 over-expression plasmid and the
expression of luciferase reporter gene was monitored. It could be
clearly seen that luciferase expression was significantly increased
when Sp1 was also over-expressed (Figure S3A compare bar 2
with bar 1). However, when the Sp1 motif was mutated no such
Sp1 mediated enhancement in luciferase gene was seen (Figure
S3B, compare bar 2 and 3 with bar 1). These results convincingly
demonstrate that Sp1 is able to cause enhanced expression of
resistin gene not just under in vitro conditions but also in vivo.
Sp1 interacts with PPARc to determine the constitutive
expression of human resistin in U937 cells
Having determined that Sp1 is the major transcriptional
regulator of resistin gene expression in U937 cells, it was important
to identify other interacting partners of Sp1, since Sp1 is known to
cross-talk with the basal transcriptional machinery at the TATA-
less promoter [31,34] as well as with transcription factors bound to
either activator or enhancer sequences [35–38]. EMSA was
performed using radio labeled hres Sp1 oligonucleotide and nuclear
extracts prepared from U937 cells. The identity of the factors
present in the protein-DNA complex was determined using super-
shift with anti-Sp1, anti-Sp3, anti-Sp4, anti- PPARc, anti-ATF-2,
anti-c-Rel, anti-C/EBP-a and anti-c-Jun antibodies (Figure 4A,
lanes 1 to 8, respectively). Anti-Sp1 antibodies (lane 1) and anti-
Sp3 antibodies (lane 2) super-shifted the protein-DNA complex.
No super-shift was observed in the presence of antibodies against
Sp4 (lane 3), ATF-2 (lane 5), c-Rel (lane 6), C/EBP-a (lane 7) or c-
Jun (lane 8). These observations indicate that Sp1 interacts with
Sp3, but not with the other transcription factors, to regulate
resistin gene expression. Interestingly, when PPARc antibody was
used (lane 4), the Sp1-Sp3 heterodimer as well as the Sp3
homodimer complex formation was completely abolished. The
disappearance of the protein-DNA complex in the presence of anti
PPARc antibodies indicates an interaction of PPARc with Sp1
and Sp3.
To further document the interaction of PPARc with Sp1
through Sp1 cognate motif present within hres regulatory
sequences, EMSA was performed using hres Sp1 oligonucleotide.
Once again the authenticity of Sp1 complex (Figure 4B, lane 2) is
evident from competition with specific homologous (lane 3) and
consensus (lane 5) unlabelled oligonucleotide but not when non-
specific oligonucleotide (lane 4) was used in competition assays.
Interestingly, 1006molar excess of unlabelled Aco-PPRE (PPARc
Response Element from Acyl-CoA oxidase gene promoter)
oligonucleotide (lane 6) and also 5006 molar excess (data not
shown) had no effect on the protein-DNAcomplex. This
observation establishes that while PPARc does not bind to Sp1
recognition sequence within the hres gene promoter, complete
disappearance of the complex with anti-PPARc antibodies
(Figure 4A, lane 4) may be due to the physical interaction
between Sp1 and PPARc.
PMA induces resistin gene expression by increasing the
recruitment of Sp1 and Sp3 to its cognate motif in
human resistin gene promoter
Earlier reports have shown that resistin is induced during the
differentiation of monocyte to macrophage [10]. Given the fact
that PMA is an inducer of monocyte differentiation to macro-
Figure 4. A. PPARc recruits Sp1 and forms a complex. Super-shift
using antibodies as indicated in the corresponding lanes are listed in
the inset. Arrows show the binding and the super-shifts. B. PPARc does
not show binding to the Sp1 binding site in human resistin gene
promoter. Experiments were repeated three times.
doi:10.1371/journal.pone.0009912.g004
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determined in U937 cells. LPS has been reported to increase the
expression of human resistin gene [11], and was used as a positive
control. We therefore first established that PMA is a potent
stimulator of resistin gene expression in a concentration dependent
manner (Figure 5A). Human monocytic U937 cells were
stimulated with PMA and LPS in presence and absence of PDTC,
an inhibitor of Sp1 [39]. Quantitative RT-PCR analysis revealed
that PMA and LPS could stimulate the expression of resistin
(Figure 5B, lanes 2 and 3) while PDTC negatively regulates resistin
gene expression (Figure 5B, lane 4). Further, PDTC could inhibit
both LPS and PMA induced hres gene expression (Figure 5B, lanes
5 and 6, respectively). These results point to Sp1 mediating the
PMA and LPS induced human resistin gene expression in vivo in
U937 cells which is abrogated in the presence of PDTC, an
inhibitor of Sp1.
Having observed that PDTC, which is an inhibitor of Sp1,
decreases the basal, LPS- and PMA-induced resistin mRNA
expression, it was of interest to examine the recruitment of Sp1 to
the hres gene promoter. Cells were treated with 5 ng/ml PMA and
nuclear extract was prepared at various time points as indicated in
Figure 5C. EMSA was performed using consensus Sp1 oligonu-
Figure 5. (A,B) PMA and LPS are positive regulators of resistin gene expression and PTDC is a negative regulator as evident from
RT-PCR. U937 cells were treated with increasing concentrations of PMA for 3 hours. Quantitative RT-PCR was performed with total RNA isolated
from the cells. B. PMA induces hres expression while PDTC downregulates it. U937 cells were treated with 100 nM PMA and 5 mg/ml. LPS in the
presence or absence of 1 mM PDTC for 3 hours. Quantitative RT-PCR was performed to analyze the effect on resistin gene expression. C. PMA
enhances the recruitment of Sp1 and Sp3 transcription factors to the consensus Sp1 binding site. Sp1 activity assay using nuclear
extract prepared at different time points from PMA stimulated U937 cell. The experiments were repeated at least two times.
doi:10.1371/journal.pone.0009912.g005
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increasing time there was an increased formation of Sp1-Sp3
heterodimer as well as Sp3 homo-dimer complex (Figure 5C). This
increase in protein- DNA interaction corresponded to the PMA
induced differentiation of U937 monocytes to macrophages.
Hence, it can be concluded that Sp1 and Sp3 transcription
factors are activated during PMA induced differentiation of
monocytes and thus consequently up regulate resistin gene
expression during differentiation of U937 monocytes.
PMA abolishes the interaction of Sp1 with PPAR
PMA is known to activate Sp1 dependent transcription [40].
Further, PPARc has been implicated in the differentiation of
human macrophages [20,41–43]. Hence, it was of interest to
explore the nature of interaction between Sp1 and PPARc in hres
gene promoter upon stimulation with PMA. EMSA was
performed using hres specific Sp1 oligonucleotide as radio labeled
probe and nuclear extracts from PMA stimulated U937 cells
(Figure 6A). The identity of the factors present in the protein-DNA
complex was determined by super-shift assay using anti-Sp1, anti-
Sp3, anti-Sp4, anti-PPARc, anti-ATF-2, anti- c-Rel, anti-C/EBP-
a and anti-c-Jun antibodies (Figure 6A, lanes 2 to 9). Anti-Sp1 and
anti-Sp3 antibodies could bring about a super-shift of the DNA-
protein complex (Figure 6A, lanes 2, 3) demonstrating that PMA
does not affect the Sp1- Sp3 interaction. No super-shift was
observed in presence of either Sp4, PPARc, ATF-2, c-Rel, C/
EBP-a or c-Jun antibodies (Figure 6A, lanes 4, 6, 7, 8 and 9,
respectively). Interestingly, unlike what was observed in the
unstimulated nuclear extracts (Figure 4A, lane 4), where the
formation of the protein-DNA complex was completely abolished
when PPARc antibodies were used for super-shift, the Sp1-Sp3 as
well as the Sp3 complexes were intact in PMA stimulated U937
nuclear extract (Figure 6A, lane 5). This clearly suggests that the
interaction of Sp1 with PPARc is abolished in the PMA stimulated
U937 nuclear extracts.
To further confirm that the integrity of the protein-DNA
complex in PMA stimulated U937 nuclear extract is due to lack of
physical interaction between PPARc and Sp1 in PMA stimulated
U937 cells, specific antibodies against Sp1, Sp3 and PPARc were
used to selectively deplete these transcription factors from
unstimulated U937 nuclear extracts. Nuclear extracts from
unstimulated U937 cells were incubated individually with
antibodies against Sp1, Sp3 and PPARc followed by mopping of
the immuno-complex with Protein G sepharose beads. These
depleted nuclear extracts were used for EMSA (Figure 6B).
Decreased binding of Sp1 and Sp3 to the radio labeled probe was
Figure 6. PMA abolishes the interaction of PPARc with Sp1. A. Super-shift assay with antibodies to Sp1, Sp3, Sp4, PPARc, ATF-2, c-Rel, C/EBP-a
and c-Jun using nuclear extracts prepared from PMA stimulated U937 cells. No super-shifting of the complex was observed in the presence of PPARc
antibody. Note that in lane 5 where PPARc antibodies were used, the Sp1-Sp3 as well as the Sp3 complex was intact. B. Partial removal of PPARc from
U937 nuclear extract does not affect the recruitment of Sp1-Sp3 complex. EMSA with U937 nuclear extracts depleted of Sp1, Sp3 and PPARc as
indicated. Experiments were done twice.
doi:10.1371/journal.pone.0009912.g006
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(Figure 6B, compare lane 3 with lanes 4 and 5). Interestingly, it
was observed that PPARc depleted nuclear extract showed a slight
increase in binding (Figure 6B, compare lane 3 with lanes 6). This
observation suggests that the removal of PPARc marginally
increased the recruitment of Sp1 and Sp3 to the hres Sp1
oligonucleotide. Removal of PPARc from unstimulated U937
nuclear extract mimicked the state of nuclear extract from PMA
induced U937 cells where the physical interaction of PPARc with
Sp1 was abolished leading to the enhanced transcriptional activity
of resistin gene promoter.
Direct interaction between Sp1 and PPARc was further
confirmed by co immuno-precipitation experiments. Whole cell
extracts from PMA stimulated or unstimulated U937 cells were
immune-precipitated with anti- Sp1 antibodies and immune-
blotted with PPARc antibodies and vice versa (Figure 7). It could
be seen that PPARc co-precipitated with Sp1 in unstimulated
extracts (Figure 7A and B, lane 1). Interestingly, neither Sp1 nor
PPARc could be detected when immune-precipitation was carried
out using PMA stimulated whole cell extracts (Figure 7A and B,
lane 2). These observations indicate that Sp1 interacts directly with
PPARc in unstimulated U937 cells and this interaction is
abolished upon stimulation with PMA.
Functional involvement of Sp1 and PPARc in human
resistin regulation
To categorically validate the functional significance of the
various transcription factor binding motifs within the hres gene
promoter, ChIP (Chromatin Immuno-precipitation assay) was
carried out. U937 cells were treated with 5 ng/ml PMA for
5 hours and chromatin was immune-precipitated using antibodies
specific to different transcription factors. PCR was performed with
immune-precipitated DNA to amplify the 535 bp region from
2213 to 2748 of the hres gene promoter (Figure 8). Antibodies to
c-Rel (Panel 3), C/EBP- a (Panel 4) and phospho c-Jun (Panel 5)
could not immune-precipitate the hres gene promoter thereby
pointing to the non-essential nature of these transcription factors
in hres gene regulation.
Immuno-precipitation of the hres gene promoter with antibodies
to HDAC 1 (Panel 6), acetylated form of histone H3 at lysine 9
(Panel 7), phospho ATF-2 (Panel 8), Sp1 (Panel 9), Sp3 (Panel 10)
and PPARc (Panel 11) points to their role in the transcription of
human resistin. It could also be seen that the binding of phospho
ATF-2, Sp1 and PPARc transcription factors to the promoter
region was enhanced in PMA treated cells while Sp3 recruitment
to the promoter remained unchanged (Figure 8). Further, the
recruitment of HDAC 1 to the hres gene promoter is decreased in
the presence of PMA. Interestingly, no change in the acetylation
state of histone H3 was observed in presence of PMA signifying the
active state of human resistin gene promoter.
Discussion
In this paper we describe the nucleotide sequences important for
transcription of the human resistin gene which is predominantly
expressed in macrophages and has been correlated with
inflammation [11–15,44]. The optimal promoter was contained
within 80 nucleotide sequence spanning region 2238 to 2318. In
silico analysis predicted a putative c-Rel and a Sp1 binding site
within the hres upstream sequence, along with several other
putative binding sites for transcription factors including CEBP-a,
AP-1 and ATF-2. Although binding of AP-1 to its cognate motif
was observed, site-directed mutagenesis followed by transient
transfection did not show significant change in promoter activity.
Further, ChIP analysis also did not reveal recruitment of AP-1 to
the hres gene promoter, confirming the absence of any direct role
of AP-1 in the constitutive expression of human resistin. Similarly,
site-directed mutagenesis of the c-Rel binding motif did not
significantly alter hres gene promoter activity. The slight decrease
in the promoter activity in c-Rel mut construct possibly could be
due to the overlap of the c-Rel binding site with the Sp1 binding
site thereby causing reduced recruitment of Sp1. Results from
ChIP analysis confirmed that c-Rel may not have any direct role in
hres gene transcription.
It has been shown that along with C/EBP-a [21], binding of
PPARc to a distant enhancer region was responsible for the
increased expression of mouse resistin in adipocytes [23]. The
absence of this synergistic action of the C/EBP-a and PPARc
involving the ,8.8 kb upstream enhancer element in the case of
human resistin has been attributed as the reason for differential
tissue tropism [23]. Although it was earlier shown, using mouse
pre-adipocyte 3T3L1, that C/EBP-a is involved in regulation of
human resistin [22] our study did not show any evidence of the
same when human monocytic U937 cells were used. The DNA-
protein complex seen in EMSA using the putative binding site of
Figure 7. Sp1 and PPARc transcription factors interact as
evident from co-immuno precipitation and western blot
analyses. Co-immuno precipitation with Sp1 and PPARc was
performed using cell extracts prepared from PMA stimulated (PMA) or
un-stimulated (US) U937 cells. Immuno-precipitates were immuno-
blotted with Sp1 and PPARc antibodies. Bands corresponding to Sp1
and PPARc are indicated by black arrows. The IgG heavy chain is
indicated in blue. This experiment was repeated twice.
doi:10.1371/journal.pone.0009912.g007
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out with consensus C/EBP-a oligonucleotide nor could be super-
shifted using anti-C/EBP-a antibodies (Figure S1). Thus C/EBP-a
is apparently not relevant for transcription from the hres gene
promoter despite the presence of a putative C/EBP’’ binding motif
in hres. That the nucleotide sequence around this motif nonetheless
has a role in hres transcription was evident from the fact that
mutation in this region led to a slight decrease in the luciferase
reporter gene expression (data not shown). It is likely that mutation
in this C/EBP binding site (which is in close proximity to the
initiator (InR) element and the transcription start site) altered the
strength of the InR promoter resulting in decreased promoter
activity. The fact that there was no recruitment of C/EBP-a to the
human resistin gene promoter in vivo using ChIP analysis, provided
further support to the argument that C/EBP-a is not important for
hres gene regulation in monocytes.
TATA-less promoters are known to bind basal transcription
factor Sp1 or the related Sp2, 3, and 4 factors through GC-rich
sequences which is essential for initiation of transcription
[29,30,45]. Sp1 and Sp3 compete for binding to GC-boxes and
display differential activity, including parallel or opposing
transcription effects depending on the promoter [46–54] or cell
type [29]. That Sp1 and Sp3 bind to hres regulatory sequences was
further confirmed by site directed mutagenesis of Sp1 binding site
and ChIP assay. PMA, an inducer of differentiation of monocyte
to macrophage, enhanced the expression of hres in U937 cells, as
also reported earlier [10]. PDTC, an inhibitor of Sp1, not only
suppressed the basal expression of hres but also abolished both
PMA and LPS induced hres expression, suggesting that PMA and
LPS mediated induction of resistin is Sp1-dependent. It is
noteworthy that PMA induces the recruitment of Sp1 to the
target promoter. PMA induced hres expression in U937 cells was
characterized by an increased recruitment of Sp1 and ATF-2,
decreased recruitment of HDAC 1 on resistin gene promoter and
no change in the acetylated form of histone H3.
Sp1 facilitates binding of TFIID through TBP Associated
Factors (TAFs) to the promoter, which in turn, recruit RNA
polymerase II transcription machinery [31,32,55–58]. Although
the activity of Sp1 is generally believed to be constitutive, it may
have synergistic effect with many cell type-specific transcription
factors such as E2F [35], HNF3 [36], RXR [37], SREBP-1 [59],
NF-kB [60] and AP2 [61]. The interaction of PPARc with Sp1
and Sp3 is important in the regulation of many genes [62–65].
TZDs reduce resistin gene expression and this action is believed to
be mediated through PPARc [21]. The role of PPARc in
regulating mouse resistin gene expression through the intronic
sequences was earlier shown by us [26]. That PPARc binds to an
enhancer located ,8.8 kb upstream of the mouse resistin gene
transcriptional start site and this confers adipogenic expression of
mouse resistin has recently been reported [23]. However, nothing
is known about the mechanism of PPARc mediated regulation of
human resistin. In our in-silico analysis we could not find PPARc
response elements (PPRE) in the 2.3 Kb upstream or even up to
,8.8 kb upstream region of hres gene [22]. Expectedly, while there
was no evidence of direct interaction between PPARc and hres
regulatory sequences, surprisingly PPARc antibodies could abolish
the binding of Sp1 and Sp3. Additionally, a physical interaction
between PPARc and Sp1 or Sp3 was evident from co-
immunoprecipitation experiments.
Differentiation of U937 cells with PMA disrupted the Sp1-
PPARc interaction in vitro although increased in vivo recruitment of
both Sp1 and PPARc to the resistin gene promoter was evident
from ChIP assay. Hence it is likely that PPARc interaction with
Sp1 negatively regulates hres gene expression and abolishment of
this interacting during PMA treatment stimulates hres expression.
It has been reported earlier that thiazolidinediones (TZDs), could
not repress the expression of resistin gene in the presence of
mithramycin A (Sp1 binding inhibitor) in 3T3-L1 adipocytes [66].
Further it was observed that the level of O-glycosylation of Sp1
was decreased in response to TZDs. Sp1 was shown to be modified
by phosphorylation of serine and threonine residues [67]. In
addition to phosphorylation, Sp1 also has multiple potential O-
glycosylation sites that may be modified by N-acetylglucosamine
residues [68]. Recent studies show that Sp1 phosphorylation is not
a constitutive modification and is altered in response to
extracellular stimuli through a variety of signal transduction
Figure 8. In vivo recruitment of transcription factors to resistin
gene promoter. ChIP assay was performed with anti c-Rel, anti-C/EBP-
a, anti phospho-cJun, anti-HDAC1, anti-acetylated histone H3 (H3K9His
Ac), anti phospho-ATF2, anti-Sp1, anti-Sp3 and anti-PPARc antibodies
from PMA treated (PMA) or untreated (US) U937 cells. This experiment
was done thrice.
doi:10.1371/journal.pone.0009912.g008
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ylation through various signaling pathways. Taken together, it
could be possible that the PMA induced loss of interaction
between Sp1 and PPARc might be due to changes in the dynamic
post-translational modifications in either Sp1 or PPARc. That
analyses of such post-translational modifications will lead to a
better understanding of the regulation of basal as well as induced
expression of human resistin cannot be understated.
In summary, this paper identifies the cis acting elements and the
role of some of the trans-acting factors in regulating human resistin
gene expression. While C/EBP-a is essential for the expression of
mouse resistin, it does not appear to be important for human
resistin gene expression unlike the expression of mouse resistin
gene which is regulated by an enhancer containing PPARc
binding site the discovery of a physical interaction between Sp1
transcription factors and PPARc, in human macrophages,
explains how PPARc could regulate human resistin gene
expression in spite of the absence of its cognate binding site in
the resistin gene promoter.
Supporting Information
Text S1 Supplementary material.
Found at: doi:10.1371/journal.pone.0009912.s001 (0.03 MB
DOC)
Figure S1 C/EBP-a does not bind to its cognate motif present
within the human resistin regulatory sequences. EMSA was
performed using nuclear extracts prepared from U937 cells. Radio
labeled oligonucleotides containing the binding site for C/EBP-a
was incubated with 7.5 mg of nuclear extract and the protein-DNA
complex separated on a 7% TGE-acrylamide gel. Lane 1 shows
the free probe. Lane 2 is the binding of human resistin C/EBP-a
oligonucleotide to C/EBP-a. Lanes 3 and 4 show self and non-self
competition respectively. Lanes 5 and 6 show competition with the
consensus C/EBP-a oligonucleotide. Lane 7 contains antibodies to
C/EBP-a along with the nuclear extract and radio labeled probe.
Note that the radio labeled protein-DNA complex formation could
not be abolished even in the presence of 2006 consensus cold
competitor. Note that the DNA-Protein complex could not be
super shifted in the presence of anti-C/EBP-a antibodies. Human
resistin C/EBP oligonucleotide was used as the radiolabeled probe
and human resistin AP-1 oligonucleotide was used for non-self
competition.
Found at: doi:10.1371/journal.pone.0009912.s002 (0.18 MB TIF)
Figure S2 Endogenous Resistin expression is enhanced both by
Sp-1 and Sp-3 over expression but not by PPARc 2 million U937
cells were transfected with pCMV Sp1 (lane 2), pCMV Sp-3 (lane
3), PPARc (lane 4) over expression plasmids. Untransfected U937
cells served as control (Lane 1). 48 h after transfection, the cells
were harvested and RNA was isolated and semi-quantitative RT-
PCR was carried out with 1 mg RNA and resistin primers (forward
primer: accggctgcacttgtggctc; reverse primer: cgacctcagggctgca-
cacg) for 35 cycles at 55uC annealing temperature using RT-PCR
kit (Qiagen). GAPDH (forward primer: gcaccaccaactgctta; reverse
primer: ccctgttgctgtagccaaat) was used as house keeping control.
Histogram was plotted with the ratio of intensities of resistin to
GAPDH as determined by ImageJ software.
Found at: doi:10.1371/journal.pone.0009912.s003 (0.28 MB TIF)
Figure S3 Sp-1 transcription factor activates transcription from
resistin gene promoter.1 million HEK cells were transfected with
1 mg of pGLHres 0.34 k (Bar1) or pGLHres 0.34 k Sp-1mut either
alone (Fig B Bar2) or with Sp-1 over expression plasmid (Bar 3) as
described. The cells were harvested after 48 h of transfection and
processed for luciferase activity.
Found at: doi:10.1371/journal.pone.0009912.s004 (0.83 MB TIF)
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